Study of Left Side of Laparoscopic Cholecystectomy
Launched by BEIJING LUHE HOSPITAL · Sep 1, 2019
Trial Information
Current as of April 28, 2025
Unknown status
Keywords
ClinConnect Summary
1. research object (1)patients who suffered from gallstones ro cholecystic polypus. (2)Informed and consented to participate in this clinical trial (3)Number of enrolled cases：100.（About 700 cases were treated in our hospital）
2. Inclusion criteria
(1) consistent with the indications of cholecystectomy (2) no cholangitis or pancreatitis (3) no diabetes (4) the operation time is less than or equal to 1 hour 3.Exclusion criteria
1. patients with acute cholecystitis
2. cystic arterial variation causes related complications
3. patients receiving analgesic drugs after surgery 4.research method...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. consistent with the indications of cholecystectomy
- • 2. no cholangitis or pancreatitis
- • 3. no diabetes
- • 4. the operation time is less than or equal to 1 hour
- Exclusion Criteria:
- • 1. patients with acute cholecystitis
- • 2. cystic arterial variation causes related complications
- • 3. patients receiving analgesic drugs after surgery
About Beijing Luhe Hospital
Beijing Luhe Hospital, a leading medical institution in China, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge medical technology and comprehensive clinical services to enhance treatment outcomes. Its robust research programs focus on a variety of therapeutic areas, striving to contribute to the global medical community by developing safe and effective interventions. The hospital's commitment to excellence in clinical research is reflected in its collaboration with various academic and industry partners, fostering an environment that promotes scientific discovery and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Tongzhou, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials